Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Cyclacel Pharmaceuticals, Inc.Financial_Report.xls
EX-32.1 - EXHIBIT 32.1 - Cyclacel Pharmaceuticals, Inc.t1402085_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - Cyclacel Pharmaceuticals, Inc.t1402085_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Cyclacel Pharmaceuticals, Inc.t1402085_ex31-1.htm
10-Q - FORM 10-Q - Cyclacel Pharmaceuticals, Inc.t1402085_10q.htm

 

EXHIBIT 32.2

 

Certification of Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

Pursuant to 18 U.S.C. s 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Cyclacel Pharmaceuticals, Inc. ( the “Company”) hereby certifies, to such officer’s knowledge, that:

 

(i)the Quarterly Report on Form10-Q of the Company for the three months ended September 30, 2014 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

 

(ii)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 Date: November 12, 2014

/s/ Paul McBarron
  Paul McBarron
  Chief Operating Officer, Chief Financial Officer
   and Executive Vice President, Finance